SAPONARA SIMONA

Simona
Saponara
Professore Associato

Office hours

  • Monday from 09:30 to 11:30
    Place: Studio del docente - Polo Scientifico Universitario di San Miniato
    Note: Previo appuntamento

Contacts

0577235378 [int.5378],0577232369 [int.2369],0577235379 [int.5379]

Curriculum Vitae

Teaching activities

Completion accademic year: 2025/2026

Course year: 1 Second cycle degree (Laurea Magistrale) BIOLOGY A.Y. 2025/2026
Course year: 3 Full cicle (5 years) PHARMACY A.Y. 2023/2024
Course year: 5 Full cicle (5 years) PHARMACY A.Y. 2021/2022
Course year: 2 First cycle degree (DM 270) CARDIOCIRCULATORY AND CARDIOVASCULAR PERFUSION TECHNIQUES A.Y. 2024/2025

Completion accademic year: 2024/2025

Course year: 1 Second cycle degree (Laurea Magistrale) BIOLOGY A.Y. 2024/2025
Course year: 3 Full cicle (5 years) PHARMACY A.Y. 2022/2023
Course year: 5 Full cicle (5 years) PHARMACY A.Y. 2020/2021
Course year: 2 First cycle degree (DM 270) CARDIOCIRCULATORY AND CARDIOVASCULAR PERFUSION TECHNIQUES A.Y. 2023/2024

Completion accademic year: 2023/2024

Course year: 3 Full cicle (5 years) PHARMACY A.Y. 2021/2022

Research

Research Interests

Novel natural as well synthetic modulators of ionic currents (Ca2+ and K+) in vascular smooth muscle cells and cardiomyocytes

Cardiovascular effects of polyphenols

Cardiovascular liabilities of novel multidrug resistance reverting agents and antineoplastic drugs

 

Expertise

Cell viability assays (necrosis, apoptosis, autophagy, cell cycle analysis), mitochondrial function, redox state, cell imaging

Patch-clamp analysis of ionic currents (Na+, Ca2+ and K+ channels, i.e. Kv11.1(hERG) - the target of virtually all QT interval-prolonging torsadogenic drugs) in single cell;

Evaluation of vascular responsiveness to various agents in rat aorta rings and single myocytes

Evaluation of cardiac function and ECG recording in Langendorff-perfused rat heart. Assessment of cardiac damage in homogenized hearts and concentrated coronary effluent (assessment of creatine kinase and troponin T, NT-proBNP)

 

Ultime pubblicazioni:

  • Carullo, G., Falbo, F., Tudino, V., Song, J., Fava, M., Fontana, A., et al. (2026). Targeting Class I Histone Deacetylases Triggers Antitumor Responses in Colorectal Cancer In Vitro and In Vivo. JOURNAL OF MEDICINAL CHEMISTRY, 69(2), 1049-1074 [10.1021/acs.jmedchem.5c02237]. - view more
  • Fusi, F., Saponara, S., Carullo, G., Panti, A., Bichicchi, A., Pifferi, A., et al. (2025). The insulin-releasing agent quercetin-3-oleate stimulates CaV1.2 channels similarly to quercetin, though with a reduced vasorelaxant activity. EUROPEAN JOURNAL OF PHARMACOLOGY, 1003 [10.1016/j.ejphar.2025.177902]. - view more
  • Fontana, A., Bergantini, L., Carullo, G., Scalvini, L., D'Alessandro, M., Papulino, C., et al. (2025). Spirotetrahydroisoquinoline-Based Histone Deacetylase Inhibitors as New Antifibrotic Agents: Biological Evaluation in Human Fibroblasts from Bronchoalveolar Lavages of Idiopathic Pulmonary Fibrosis Patients. ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 8(2), 380-393 [10.1021/acsptsci.4c00456]. - view more
  • Cursaro, I., Frattaruolo, L., Scalvini, L., Contri, C., Bichicchi, A., Tardiolo, N., et al. (2025). New Vanillyl-capped HDAC inhibitors exhibit anti-tumor efficacy in neuroblastoma and glioblastoma cells. BIOORGANIC CHEMISTRY, 166 [10.1016/j.bioorg.2025.109085]. - view more
  • Koszelewski, D., Ostaszewski, R., Zaremba, A., Riganti, C., Kopecka, J., Contino, M., et al. (2025). New dimension of ciprofloxacin hybrids: Synthesis, characterization and anticancer evaluation of newly C3-modified ciprofloxacin derivatives. BIOORGANIC CHEMISTRY, 164 [10.1016/j.bioorg.2025.108863]. - view more